Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer

Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer

Abstract While mammograms are the standard tool for breast cancer screening, there remains challenges for mammography to effectively distinguish benign lesions from breast cancers, leading to many unnecessary biopsy procedures. A blood-based biomarker could provide a minimally invasive supplemental...

Full description

Bibliographic Details
Main Authors: Calvin R. K. Blaschke, Elizabeth G. Hill, Anand S. Mehta, Peggi M. Angel, Christine Laronga, Richard R. Drake
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25401-0

Internet

https://doi.org/10.1038/s41598-022-25401-0

Similar Items